Feature

Pacylex reshaping cancer treatment with a novel once-daily oral therapy

Closely held Pacylex Pharmaceuticals is developing a first-in-class oral cancer therapy with a novel, broad mechanism of action designed for refractory cancers as both a monotherapy and a future combination therapy.

May 26, 2026

Feature

illumiSonics expanding the limits of tissue imaging with a single scan

Closely held illumiSonics is addressing a significant unmet medical need by redefining tissue imaging with its proprietary multi-laser imaging (MLI) platform, an advanced modality designed for life sciences research...

May 19, 2026

Feature

Adagio delivering first-of-its-kind innovation in cardiac ablation technology

Adagio Medical (NASDAQ: ADGM) is innovating catheter ablation technologies for the treatment of one of the most challenging and underserved areas in electrophysiology—ventricular tachycardia (VT), a dangerous type of...

May 5, 2026

Feature

Niagen Bioscience innovating NAD+-based therapies from healthy aging to pediatric orphan diseases

Niagen Bioscience (NASDAQ: NAGE) is pioneering the research and development of nicotinamide adenine dinucleotide (NAD+)—a vital coenzyme essential to cellular metabolism, energy production, and DNA repair that declines...

April 28, 2026